Displaced Orbital Fractures with Concurrent Orbital Compartment Syndrome: A Case-Based Systematic Review

Author(s):  
Serge Zogheib ◽  
Georges Sukkarieh ◽  
Georges Mjaess ◽  
Samer Abou Zeid

AbstractOrbital compartment syndrome (OCS) is an emergency that complicates intra-orbital, retrobulbar hemorrhage in most cases. Bony orbital decompression is an effective treatment for OCS, and displaced orbital fractures are protective. Nevertheless, in rare cases, OCS occurs despite a displaced orbital fracture. The aim of the current review is to present its pathophysiology and management based on what is published in the medical literature, and our center's experience. A systematic review of literature was conducted through PubMed, Medline, Embase, and Cochrane from inception through February 2021. The following search query was used: “orbital fracture” and “trauma” and “orbital compartment syndrome.” Studies tackling the pathophysiology and management of concurrent displaced orbital fracture with OCS were included and a cohort of patients was constituted. A cohort of 18 cases reported in the literature were included (49.3 ± 30.6 years, 50% M). Given that OCS occurs with or without orbital fracture, pathophysiology of OCS is mostly explained by the division of the orbital fat into many compartments, due to the presence of Koorneef's fibrous septa. Management of OCS in such circumstances consisted of inferior-lateral canthotomy and cantholysis in 50% of cases, subperiosteal drainage with myringotomy in 22.2% of cases, subperiosteal drainage in 16.7% of cases, and complete lateral cantholysis in 16.7% of cases. Two cases who presented to our tertiary care center were also added to this review. Physicians should be aware that OCS can occur even with displaced fractures of the orbital cavity. When clinical suspicion is present, an emergent management is needed.

Author(s):  
Vinicius Teixeira Botelho ◽  
MELINE ROSSETTO RODRIGUES ◽  
Guilherme Augusto Rago Ferraz ◽  
Cassiana Mendes Bertoncello Fontes ◽  
Maria Helena Borgato ◽  
...  

This systematic review evaluated whether reiki had an impact on patients undergoing chemo-therapy, with possible improvement of the following outcomes: fatigue, pain, anxiety and quality of life. Method: Systematic review study with meta-analysis conducted at a tertiary care center. The following databases were searched until July 2020: MEDLINE, LILACS and CENTRAL. Two re-viewers independently examined eligible articles, extracted data and assessed the risk of bias using the Cochrane tool. Results: The analyzes included eight studies and showed that there was a sta-tistically significant for anxiety control (MD = -2-09; 95% CI: -3.00 to -1.19; I2 = 51%) and Quality of life (MD = -5.97; 95% CI: -10.70 to -1.25; I2 = 97%) but no statistically significant difference was found for the other outcomes analyzed. An analysis of the risk of bias has uncertain methodological limitations in the studies. Conclusions: Although there is anxiety control and improved quality of life, there is a need for the elaboration of randomized clinical trials with larger populations to verify their real performance in controlling some side effects during chemotherapy.


2019 ◽  
Vol 5 (02) ◽  
pp. 53-57
Author(s):  
Vimalin Samuel ◽  
Dheepak Selvaraj ◽  
Albert Abhinay Kota ◽  
Edwin Stephen

Abstract Introduction Prostaglandins are potent vasoactive agents with other properties of vasodilatation, fibrinolysis and inhibition of platelet aggregation. Prostaglandin E1 (PGE1) has been used in the treatment of peripheral vascular diseases (PVD), mainly in patients with nonreconstructable PVD and also as an adjunct when there is residual ischemia after revascularization. Our experience in using PGE1 at a tertiary care center in South India is presented here along with a review of literature. Materials and Methods Patients presenting to us with nonreconstructable critical limb ischemia underwent prostaglandin infusion after meeting selection criteria. Results Of the 142 patients enrolled into the study, 48 completed the study. There was a shift in the profile of patients from critical limb ischemia to claudicants or minor tissue loss. Discussion In the absence of options to treat patients with nonreconstructable critical limb ischemia, prostaglandin infusion offers a viable option for treatment. Conclusion PGE1 infusion is an option for patients with nonreconstructable critical limb ischemia.


2021 ◽  
Author(s):  
Saurav Sekhar Paul ◽  
Rohit Kumar ◽  
Ved Prakash Meena ◽  
Aishwarya Ramprasad ◽  
Prerna Garg ◽  
...  

Abstract Background-The sharp uptick in the cases of mucormycosis in the background of the COVID19 pandemic is a cause of concern and the reasons and it’s impact remains to be seen. We studied the clinical characteristics in patients with mucormycosis and COVID19 co-infection and performed a literature review.Methods-This retrospective study was conducted at tertiary centre in India. All patients admitted with COVID19 and mucormycosis were included, clinical details were obtained from hospital records. We did review of literatures using the terms “SARS-CoV2” OR “COVID19” AND “Mucormycosis” AND “co-infection” on Pubmed published before February 20, 2021.Results-Sixteen cases (M:F–13:3), mean age 46·5 years (24-75years), were included. Fourteen had known risk factors for mucormycosis, the most common being diabetes mellitus. Most patients (n=14) were symptomatic with mucormycosis before diagnosis of COVID19. There was delay in surgery by 22.5 days (IQR–>17.75–29.5), pending SARS-CoV-2 RT-PCR negativity. There were six deaths in this cohort, unrelated to the COVID19 severity. The literature review revealed eleven case reports on co-infection. Patients who had developed mucormycosis were found to have history of mechanical ventilation.Conclusion-The apparent increase in the incidence of mucormycosis may be due to decompensation of underlying comorbidities (decreased access to healthcare), and increased use of immunosuppressants in COVID19. Patients with co-infection were noted to have poorer outcomes.


2016 ◽  
Vol 5 (5) ◽  
pp. 461 ◽  
Author(s):  
Geetika Singh ◽  
Lavleen Singh ◽  
Ranajoy Ghosh ◽  
Devajit Nath ◽  
Amit Kumar Dinda

2021 ◽  
Vol 69 (7) ◽  
pp. 206
Author(s):  
Daljit Singh ◽  
Gautam Dutta ◽  
Anita Jagetia ◽  
Hukum Singh ◽  
ArvindK Srivastava ◽  
...  

2020 ◽  
Vol 09 (01) ◽  
pp. 42-48 ◽  
Author(s):  
Rajanandhan Viswanathan ◽  
Venkatesan Sanjeevi ◽  
Balasubramanian Dhandapani

AbstractPneumocephalus has various forms of presentations and a diverse etiology ranging from trauma to iatrogenic craniotomies and spinal surgeries. Most cases are benign and uncomplicated and resolve with minimal or no intervention. Few cases of pneumocephalus or pneumoventricles are either persistent despite treatment or present in various unique forms leading to considerable difficulty in the diagnosis and management of these patients. In this study, we analyze six cases of pneumocephalus with unusual and rare form of presentations and discuss their management strategies along with a review of relevant literature.


2016 ◽  
Vol 9 (2) ◽  
pp. 109-112 ◽  
Author(s):  
Alexandra G. Kesselring ◽  
Paul Promes ◽  
Elske M. Strabbing ◽  
Karel G. H. van der Wal ◽  
Maarten J. Koudstaal

The aim of this study is to analyze the development of lower eyelid malposition following reconstruction of orbital fractures, in relation to the incisions used for access. A total of 198 surgical orbital floor reconstructions were performed in 175 patients between 2001 and 2011. Preoperative and postoperative presence of lower eyelid malposition of patients was reported. The types of incision used for access were as follows: approach via laceration (4.5%), via preexisting scar (16.2%), infraorbital (40.9%), subciliar (23.7%), transconjunctival (13.1%), and transconjunctival with lateral canthotomy (1.5%). The incidence of ectropion development following surgery was 3.0% and the incidence of entropion development following surgery was 1.0%. The highest rate of ectropion (11.1%) was seen using an approach via a laceration, followed by approach via a scar (6.3%). Our conclusion is that the transconjunctival incision without a lateral canthotomy has a low complication rate, provides adequate exposure, and leaves no visible scar.


Sign in / Sign up

Export Citation Format

Share Document